ES2056660T3 - Forma de dosificacion para pautas de suministro de farmacos variables con el tiempo. - Google Patents

Forma de dosificacion para pautas de suministro de farmacos variables con el tiempo.

Info

Publication number
ES2056660T3
ES2056660T3 ES91915824T ES91915824T ES2056660T3 ES 2056660 T3 ES2056660 T3 ES 2056660T3 ES 91915824 T ES91915824 T ES 91915824T ES 91915824 T ES91915824 T ES 91915824T ES 2056660 T3 ES2056660 T3 ES 2056660T3
Authority
ES
Spain
Prior art keywords
dosage form
variable
over time
drug
pharmacy supply
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91915824T
Other languages
English (en)
Inventor
Patrick S-L Wong
Felix Theeuwes
Atul Devdatt Ayer
Anthony L Kuczynski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24302741&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2056660(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ES2056660T3 publication Critical patent/ES2056660T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
  • Bus Control (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)

Abstract

SE PRESENTA UNA FORMA DE DOSIFICACION (10) QUE COMPRENDE MEDIOS (18) DENTRO DE LA FORMA DE DOSIFICACION PARA SUMINISTRAR UN INTERVALO LIBRE DE SUMINISTRO DE DROGAS ANTES DE QUE LA FORMA DE DOSIFICACION SUMINISTRE UNA DROGA (15) DESDE EL INTERIOR DE LA FORMA DE DOSIFICACION. LA FORMA DE DOSIFICACION EN UNA DE SUS CONFORMACIONES COMPRENDE UNA DROGA SOBRE EL EXTERIOR DE LA FORMA DE DOSIFICACION, DICHA DROGA ESTA DISPONIBLE PARA SU SUMINISTRO INMEDIATO.
ES91915824T 1990-08-31 1991-08-28 Forma de dosificacion para pautas de suministro de farmacos variables con el tiempo. Expired - Lifetime ES2056660T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/576,042 US5156850A (en) 1990-08-31 1990-08-31 Dosage form for time-varying patterns of drug delivery

Publications (1)

Publication Number Publication Date
ES2056660T3 true ES2056660T3 (es) 1994-10-01

Family

ID=24302741

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91915824T Expired - Lifetime ES2056660T3 (es) 1990-08-31 1991-08-28 Forma de dosificacion para pautas de suministro de farmacos variables con el tiempo.

Country Status (18)

Country Link
US (2) US5156850A (es)
EP (1) EP0546038B1 (es)
JP (1) JP2796433B2 (es)
KR (1) KR0162106B1 (es)
AT (1) ATE108999T1 (es)
AU (1) AU648822B2 (es)
CA (1) CA2088376C (es)
DE (1) DE69103153T2 (es)
DK (1) DK0546038T3 (es)
ES (1) ES2056660T3 (es)
FI (1) FI107699B (es)
IE (1) IE67163B1 (es)
MX (1) MX9100838A (es)
NO (1) NO304580B1 (es)
NZ (1) NZ239574A (es)
PT (1) PT98802B (es)
WO (1) WO1992004011A1 (es)
ZA (1) ZA916802B (es)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
US5422122A (en) * 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
KR100355130B1 (ko) * 1992-09-18 2003-01-30 야마노우치세이야쿠 가부시키가이샤 하이드로겔서방성정제
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
ATE325606T1 (de) * 1996-11-25 2006-06-15 Alza Corp Dosisform mit ansteigender dosisfreisetzung
EP1782798A3 (en) 1996-11-25 2008-05-21 Alza Corporation Ascending-dose dosage form
US5788987A (en) 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
IT1291652B1 (it) * 1997-04-24 1999-01-19 Apr Trading Sa Composizioni farmaceutiche a copertura terapeutica programmata
US6962997B1 (en) * 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
DE19747261A1 (de) * 1997-10-25 1999-04-29 Bayer Ag Osmotisches Arzneimittelfreisetzungssystem
US8524277B2 (en) 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US5945123A (en) * 1998-04-02 1999-08-31 K-V Pharmaceutical Company Maximizing effectiveness of substances used to improve health and well being
KR100827254B1 (ko) * 1998-06-03 2008-05-07 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
AU5062099A (en) * 1998-07-21 2000-02-14 Alpenstock Holdings Limited An antilipemic formulation
US20010055613A1 (en) * 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
CA2348871C (en) 1998-11-02 2009-04-14 John G. Devane Multiparticulate modified release composition
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6387403B1 (en) 1999-09-15 2002-05-14 Alza Corporation Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
US6610674B1 (en) * 1999-09-28 2003-08-26 University Of Pennsylvania Method of treating inflammatory conditions with progesterone analogs
KR20020059653A (ko) 1999-10-29 2002-07-13 그린 마틴, 브라이언 쥐 테슬리 서방성 하이드로코돈 제형
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
WO2001047498A2 (en) 1999-12-23 2001-07-05 Pfizer Products Inc. Hydrogel-driven layered drug dosage form comprising sertraline
BR0016708A (pt) * 1999-12-23 2002-10-08 Pfizer Prod Inc Forma de dosagem de droga baseada em hidrogel
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
HU230686B1 (en) * 2000-10-30 2017-08-28 Euro Celtique Sa Controlled release hydrocodone compositions
US20110104214A1 (en) * 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
HUP0401079A3 (en) * 2001-07-10 2008-04-28 Teva Pharma Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
WO2003051341A1 (en) * 2001-12-18 2003-06-26 Alza Corporation Dosage form for providing time-varying patterns of drug delivery
EP1465606A4 (en) * 2001-12-24 2009-04-22 Teva Pharma DOSAGE FORM WITH PASTILLE CORE ACTIVE PRINCIPLE COATED IN COMPRESSED ANNULAR BODY OF POWDER OR GRANULAR SUBSTANCE, AND METHOD AND TOOLS FOR PRODUCTION OF SAID DOSAGE FORM
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
US20050106249A1 (en) * 2002-04-29 2005-05-19 Stephen Hwang Once-a-day, oral, controlled-release, oxycodone dosage forms
US20040010000A1 (en) * 2002-04-29 2004-01-15 Ayer Atul D. Methods and dosage forms for controlled delivery of oxycodone
AU2003245345A1 (en) * 2002-05-31 2003-12-19 Alza Corporation Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
US20040005359A1 (en) * 2002-06-27 2004-01-08 Cheng Xiu Xiu Controlled release oral dosage form
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
DE60316454T2 (de) * 2002-07-29 2008-06-26 Alza Corp., Mountain View Verfahren und dosierformen für die kontrollierte abgabe von paliperidon
MXPA05001184A (es) * 2002-07-29 2005-09-12 Johnson & Johnson Formulaciones y formas de dosificacion para administracion controlada de topiramato.
US20050208132A1 (en) * 2002-07-29 2005-09-22 Gayatri Sathyan Methods and dosage forms for reducing side effects of benzisozazole derivatives
WO2004012705A1 (en) * 2002-07-31 2004-02-12 Phafag Ag A pharmaceutical formulation and its use in the treatment of inner ear diseases
US6913768B2 (en) * 2002-09-24 2005-07-05 Shire Laboratories, Inc. Sustained release delivery of amphetamine salts
EP1575569B1 (en) 2002-12-13 2010-09-29 Durect Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
US8293799B2 (en) * 2003-12-29 2012-10-23 Osmotica Keresleedelmo és Szolgáltató KFT Osmotic device containing a venlafaxine salt and a salt having an ion in common
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
KR20050095835A (ko) * 2003-01-14 2005-10-04 알자 코포레이션 조정된 점성층을 갖는 방법 및 제형
US20040197407A1 (en) * 2003-02-11 2004-10-07 Ramkumar Subramanian Methods and dosage forms with modified layer geometry
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
AU2004264316A1 (en) * 2003-08-06 2005-02-24 Alza Corporation Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
AU2004268549A1 (en) * 2003-08-22 2005-03-10 Alza Corporation Stepwise delivery of topiramate over prolonged period of time
AU2004268661A1 (en) * 2003-09-02 2005-03-10 Alza Corporation Novel drug compositions and dosage forms of topiramate
MXPA06003451A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Formas de dosificacion osmotica para suministro controlado de alprazolam.
AU2004314693B2 (en) 2003-09-26 2011-04-07 Alza Corporation Drug coating providing high drug loading and methods for providing the same
WO2005030181A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Controlled release formulations of opioid and nonopioid analgesics
US20070259033A1 (en) 2003-09-26 2007-11-08 Evangeline Cruz Controlled release formulations exhibiting an ascending rate of release
US20050163841A1 (en) * 2003-10-31 2005-07-28 Wong Patrick S. Compositions and dosage forms for enhanced absorption of 3-amino-n-butyl-phosphinic acid
US20050169992A1 (en) * 2003-12-23 2005-08-04 Frank Jao Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
US20050175696A1 (en) * 2003-12-29 2005-08-11 David Edgren Drug granule coatings that impart smear resistance during mechanical compression
CA2550699A1 (en) * 2003-12-29 2005-07-21 Alza Corporation, Inc. Novel drug compositions and dosage forms of topiramate
JP2007517061A (ja) * 2003-12-29 2007-06-28 アルザ・コーポレーシヨン 新規薬剤組成物及び投与形態物
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
WO2006007323A2 (en) * 2004-06-28 2006-01-19 Alza Corporation Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents
US8541026B2 (en) * 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
NZ555842A (en) * 2004-12-09 2010-10-29 Celgene Corp Treatment of various conditions of patients with Tourette syndrome, tics, or a family history thereof sing D-threo methylphenidate free from other isomers
WO2006081569A2 (en) * 2005-01-27 2006-08-03 Alza Corporation Oral osmotic dosage form having a high flux membrane
EP1874269A2 (en) * 2005-04-19 2008-01-09 Alza Corporation Combination of tramadol and substances that comprise gabapentin
JP2009500339A (ja) * 2005-06-29 2009-01-08 アルザ・コーポレーシヨン 浸透性剤形のための低下された乾燥時間を提供する半透過性組成物
WO2007106111A2 (en) * 2005-07-01 2007-09-20 Elan Pharma International Limited Nanoparticulate and controlled release compositions comprising nilvadipine
US20070031496A1 (en) * 2005-08-04 2007-02-08 Edgren David E Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
US8778395B2 (en) * 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
US20070190137A1 (en) * 2005-10-07 2007-08-16 Reyes Iran Osmotic dosage form with controlled release and fast release aspects
PL116330U1 (en) 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
US20070196487A1 (en) * 2006-02-16 2007-08-23 Geerke Johan H Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
BRPI0709606B8 (pt) 2006-03-16 2021-05-25 Tris Pharma Inc suspensão líquida administrável oralmente com características de liberação modificada
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
WO2008021875A2 (en) * 2006-08-08 2008-02-21 Accu-Break Technologies, Inc. Pharmaceutical tablets containing a plurality of active segments
CA2674039A1 (en) * 2006-12-28 2008-07-17 Astellas Pharma Inc. Sustained release formulation for tacrolimus
US8524749B2 (en) * 2007-02-09 2013-09-03 Alza Corporation Controlled release compositions of tizanidine
WO2008105920A1 (en) * 2007-02-28 2008-09-04 Collegium Pharmaceutical, Inc. Antihistamine combination
US8415401B2 (en) 2007-12-06 2013-04-09 Durect Corporation Oral pharmaceutical dosage forms
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
WO2009137827A2 (en) * 2008-05-09 2009-11-12 Tiara Pharmaceuticals, Inc. Controlled release of n-acetylcysteine (nac) for reduction of systemic and/or vascular inflammation
CN102112115A (zh) * 2008-07-30 2011-06-29 万能药生物有限公司 雷米普利调节释放组合物及其应用
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
WO2010077925A2 (en) 2008-12-16 2010-07-08 Teva Pharmaceutical Industries Ltd. Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidate
US8568793B2 (en) * 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
WO2011032386A1 (zh) 2009-09-15 2011-03-24 北京天衡药物研究院 一种渗透泵型控释片及其制备方法
TR201802207T4 (tr) 2010-03-29 2018-03-21 Astellas Pharma Inc Kontrollü Salımlı Farmasötik Bileşim.
US20130011477A1 (en) * 2010-03-29 2013-01-10 Hetero Research Foundation Stable Pharmaceutical Composition of Imatinib
US8287903B2 (en) 2011-02-15 2012-10-16 Tris Pharma Inc Orally effective methylphenidate extended release powder and aqueous suspension product
ES2680549T3 (es) * 2012-01-17 2018-09-10 Croda, Inc. Uso de un diéster de isosorbida como aditivo de hinchamiento de juntas
EP2884961B1 (en) 2012-08-15 2019-03-06 Tris Pharma Inc. Methylphenidate extended release chewable tablet
CN105120659A (zh) 2013-03-15 2015-12-02 度瑞公司 用于降低溶解可变性的具有流变改性剂的组合物
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US9707217B1 (en) 2017-02-03 2017-07-18 Osmotica Kereskedelmi Es Szolgaltato Kft Dose-dumping resistant controlled release dosage form
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
WO2019161307A1 (en) 2018-02-16 2019-08-22 Esperion Therapeutics, Inc. Sustained release formulations of bempedoic acid
ES2909803T3 (es) 2018-03-05 2022-05-10 Amneal Complex Products Res Llc Composiciones farmacéuticas programables para la cronoliberación de fármacos
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
EP3934622A1 (en) 2019-03-05 2022-01-12 Amneal Complex Products Research LLC Delayed release methylphenidate compositions
CN114681422B (zh) * 2020-12-30 2023-09-05 深圳翰宇药业股份有限公司 一种硝苯地平控释片及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4318400A (en) * 1980-01-18 1982-03-09 Alza Corporation Medical infusor
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4863744A (en) * 1984-09-17 1989-09-05 Alza Corporation Intestine drug delivery
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
US4950486A (en) * 1987-10-02 1990-08-21 Alza Corporation Dosage form for treating cardiovascular diseases
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
US4966769A (en) * 1988-06-02 1990-10-30 Alza Corporation Method for delivering dosage form for diltiazem
JPH04503058A (ja) * 1989-01-30 1992-06-04 アルザ コーポレイション カルシウム拮抗体投与のための剤形
FI900470A0 (fi) * 1989-01-31 1990-01-30 Int Pharma Agentur Aktivaemnen kontrollerat avgivande system och foerfarande foer dess framstaellning.
US4984592A (en) * 1989-12-18 1991-01-15 Christine Hellein Manicure shield
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device

Also Published As

Publication number Publication date
NZ239574A (en) 1993-10-26
DK0546038T3 (da) 1994-11-28
DE69103153D1 (de) 1994-09-01
NO930604L (no) 1993-02-26
CA2088376A1 (en) 1992-03-01
FI930862A (fi) 1993-02-25
AU8500091A (en) 1992-03-30
PT98802A (pt) 1993-12-31
ZA916802B (en) 1992-05-27
NO930604D0 (no) 1993-02-22
EP0546038B1 (en) 1994-07-27
JPH06500774A (ja) 1994-01-27
WO1992004011A1 (en) 1992-03-19
FI107699B (fi) 2001-09-28
MX9100838A (es) 1992-04-01
CA2088376C (en) 2001-05-01
DE69103153T2 (de) 1994-11-24
AU648822B2 (en) 1994-05-05
KR930701156A (ko) 1993-06-11
KR0162106B1 (ko) 1998-12-01
US5785994A (en) 1998-07-28
FI930862A0 (fi) 1993-02-25
US5156850A (en) 1992-10-20
IE913023A1 (en) 1992-03-11
JP2796433B2 (ja) 1998-09-10
NO304580B1 (no) 1999-01-18
IE67163B1 (en) 1996-03-06
PT98802B (pt) 1999-01-29
EP0546038A1 (en) 1993-06-16
ATE108999T1 (de) 1994-08-15

Similar Documents

Publication Publication Date Title
ES2056660T3 (es) Forma de dosificacion para pautas de suministro de farmacos variables con el tiempo.
NO933728L (no) Doseringsform
ATE444768T1 (de) Wirkstoffabgabesysteme
HN1999000158A (es) Sistemas de entrega controlado de droga administrado oralmente que provee control temporal y espacial
DE69427472D1 (de) Arzneimittel mit kontrollierter Wirkstoffabgabe
DE69611369T2 (de) Sublingual oder bukkal verabreichte arzneistoffe mit gesteuerter freisetzung
BR9407238A (pt) Dispositivo implantável de fornecimento de droga
MX9207263A (es) Sistema para el suministro de una substancia activa para la liberacion sostenida.
ES2167609T3 (es) Formulaciones de quinolona inyectables.
NO973630D0 (no) System for regulert avgivelse av medikament
ES2148838T3 (es) Oligonucleotidos antisentido contra la subunidad reguladora alfa de la proteina quinasa dependiente de camp para el tratamiento del cancer.
MX9305472A (es) Dispositivo distribuidor de medicamento.
ATE183392T1 (de) Transdermale therapeutische systeme zur verabreichung von serotoninagonisten
DE69004415D1 (de) Vorrichtung zur verzögerten Abgabe von pharmakologisch aktiven Verbindungen ins Ohr.
BR9608255A (pt) Sistema terapéutico transdérmico (stt) para a administração de testosterona
DE69002034T2 (de) Vorrichtung mit gesteuerter Wirkstoffabgabe.
DE69626544T2 (de) Arzneistoffe
NO179504C (no) Legemiddel i form av en tablett inneholdende diritromycin
ES2085656T3 (es) Forma de administracion peroral de medicamentos peptidicos, en particular insulina.
AR001070A1 (es) Forma de aplicación para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmacéuticamente aptas y procedimiento para la elaboración de la forma de aplicación
ES2069897T3 (es) Forma de dosificacion para administrar un farmaco para realizar una terapia circadiana.
CO4440564A1 (es) Sistema de componentes de dispensador de tabletas con dia de inicio variable y metodos para llenar el dispensador y para administrar el regimen prescrito
MX9207389A (es) Entrega transdermica de activadores cognoscitivos para el mejoramiento de la memoria.
FR2685870B1 (fr) Medicament anticancereux.
UA23119A (uk) Психотропhий засіб

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 546038

Country of ref document: ES